Smith & Nephew plc (SNN)

USD 24.89

(-2.16%)

EBITDA Summary of Smith & Nephew plc

  • Smith & Nephew plc's latest annual EBITDA in 2023 was 979 Million USD , up 31.42% from previous year.
  • Smith & Nephew plc's latest quarterly EBITDA in 2024 Q2 was 520 Million USD , down 0.0% from previous quarter.
  • Smith & Nephew plc reported an annual EBITDA of 1 Billion USD in 2022, down -5.43% from previous year.
  • Smith & Nephew plc reported an annual EBITDA of 1.22 Billion USD in 2021, up 27.08% from previous year.
  • Smith & Nephew plc reported a quarterly EBITDA of 612 Million USD for 2023 Q2, down 0.0% from previous quarter.
  • Smith & Nephew plc reported a quarterly EBITDA of 827.37 Million USD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Smith & Nephew plc (2023 - 1989)

Historical Annual EBITDA of Smith & Nephew plc (2023 - 1989)

Year EBITDA EBITDA Growth
2023 979 Million USD 31.42%
2022 1 Billion USD -5.43%
2021 1.22 Billion USD 27.08%
2020 839 Million USD -35.04%
2019 1.42 Billion USD 1.71%
2018 1.28 Billion USD 7.1%
2017 1.39 Billion USD -1.28%
2016 1.53 Billion USD 11.51%
2015 1.07 Billion USD -7.25%
2014 1.28 Billion USD 8.27%
2013 1.18 Billion USD 0.25%
2012 1.18 Billion USD 1.37%
2011 1.15 Billion USD -3.72%
2010 1.25 Billion USD 16.55%
2009 1.01 Billion USD 11.0%
2008 936 Million USD 8.58%
2007 721 Million USD 15.24%
2006 703 Million USD 5.35%
2005 591 Million USD 11.53%
2004 250 Million USD 15.04%
2003 265 Million USD 26.22%
2002 362.42 Million USD 39.07%
2001 313.66 Million USD -15.4%
2000 409.68 Million USD -2.31%
1999 361.29 Million USD 9.28%
1998 305.01 Million USD -1.28%
1997 340.04 Million USD -10.92%
1996 395.93 Million USD 12.28%
1995 351.84 Million USD 3.17%
1994 65.5 Million USD 8.06%
1993 332.67 Million USD 3.72%
1992 324.42 Million USD -15.68%
1991 249.8 Million USD -36.02%
1990 390.41 Million USD 24.01%
1989 314.82 Million USD 6.66%

Peer EBITDA Comparison of Smith & Nephew plc

Name EBITDA EBITDA Difference
Abbott Laboratories 10.46 Billion USD 90.643%
Allurion Technologies Inc. -69.03 Million USD 1518.203%
Artivion, Inc. 38.14 Million USD -2466.724%
Avanos Medical, Inc. 53.2 Million USD -1740.226%
Butterfly Network, Inc. -124.84 Million USD 884.179%
Butterfly Network, Inc. -124.84 Million USD 884.179%
Bio-Rad Laboratories, Inc. -608.26 Million USD 260.95%
Boston Scientific Corporation 3.45 Billion USD 71.648%
Perspective Therapeutics, Inc. -14.83 Million USD 6697.924%
CONMED Corporation 182.18 Million USD -437.363%
Edwards Lifesciences Corporation 1.76 Billion USD 44.614%
Paragon 28, Inc. -36.61 Million USD 2773.841%
Glaukos Corporation -82.11 Million USD 1292.216%
Globus Medical, Inc. 418.23 Million USD -134.077%
Inspire Medical Systems, Inc. -17.06 Million USD 5838.57%
Integer Holdings Corporation 282.05 Million USD -247.091%
Medtronic plc 9.05 Billion USD 89.189%
Nevro Corp. -78.31 Million USD 1350.16%
Owlet, Inc. -27.48 Million USD 3661.425%
Penumbra, Inc. 111.99 Million USD -774.138%
Vicarious Surgical Inc. -69.19 Million USD 1514.903%
Sonendo, Inc. -54.76 Million USD 1887.54%
STERIS plc 1.41 Billion USD 30.686%
Stryker Corporation 5.16 Billion USD 81.027%
Vapotherm, Inc. -34.35 Million USD 2949.492%
Zimmer Biomet Holdings, Inc. 2.44 Billion USD 60.023%